AJP - GI Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol 296: G899-G909, 2009. First published January 22, 2009; doi:10.1152/ajpgi.90507.2008
0193-1857/09 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
296/4/G899    most recent
90507.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zahedi, K.
Right arrow Articles by Soleimani, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zahedi, K.
Right arrow Articles by Soleimani, M.

LIVER AND BILIARY TRACT

Spermidine/spermine-N1-acetyltransferase ablation protects against liver and kidney ischemia-reperfusion injury in mice

Kamyar Zahedi,1 Alex B. Lentsch,2 Tomohisa Okaya,2 Sharon Barone,1 Nozomu Sakai,2 David P. Witte,3 Lois J. Arend,4 Leena Alhonen,5 Jason Jell,6 Juhani Jänne,5,{dagger} Carl W. Porter,6 and Manoocher Soleimani1,7

1Division of Nephrology and Hypertension and 2Department of Surgery, University of Cincinnati College of Medicine, Cincinnati; 3Division of Pathology, Children's Hospital Medical Center, Cincinnati; 4Division of Pathology, University of Cincinnati College of Medicine, Cincinnati; 5A. I. Virtanen Institute for Molecular Sciences, University of Kuopio, Kuopio, Finland; 6Roswell Park Cancer Institute, Buffalo, New York; and 7Veterans Affairs Medical Center, Cincinnati, Ohio

Submitted 22 August 2008 ; accepted in final form 12 January 2009

Expression of spermine/spermidine-N1-acetyltransferase (SSAT), the rate-limiting enzyme of polyamine backconversion cascade, increases after ischemia-reperfusion injuries (IRI). We hypothesized that SSAT plays an important role in the mediation of IRI. To test our hypothesis, wild-type (SSAT-wt) and SSAT-deficient (SSAT-ko) mice were subjected to liver or kidney IRI by ligation of hepatic or renal arteries. The liver and kidney content of putrescine (Put), a downstream by-product of SSAT activity, increased in SSAT-wt animals but not in SSAT-ko animals after IRI, indicating that polyamine backconversion is not functional in SSAT-deficient mice. When subjected to hepatic IRI, SSAT-ko mice were significantly protected against liver damage compared with SSAT-wt mice. Similarly, SSAT-ko animals subjected to renal IRI showed significantly greater protection against damage to kidney tubules than SSAT-wt mice. These studies indicate that SSAT-deficient animals are protected against IRI and suggest that SSAT is an important mediator of the tissue damage in IRI.

polyamine catabolism; polyamine backconversion; acute liver failure; acute kidney injury



Address for reprint requests and other correspondence: M. Soleimani, Division of Nephrology and Hypertension, Dept. of Medicine, Univ. of Cincinnati, 231 Albert Sabine Way, MSB 259G, Cincinnati, OH 45267-0585 (e-mail: soleimm{at}ucmail.uc.edu)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.